{"title": "PDF", "author": "PDF", "url": "https://www.samfyc.es/wp-content/uploads/2018/08/AlertaJunio2014.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Junio 2014 Selecci\u00f3n realizada por Antonio Manteca Gonz\u00e1lez ACADEMIC MEDICINE Gabel S. Expanding the scope of Med 2014;89:848 -852 [AO,I] 24662199 R/C EXPANDIR EL \u00c1MBITO DE LAS PR\u00c1CTICAS DE LIDERAZGO EN MEDICINA Grace ES, Wenghofer EF, Korinek EJ. PREDICTORE S DEL RENDIMIENTO DEL M\u00c9DICO EN LA VALORACI\u00d3N DE LA COMPETENCIA: HALLAZGOS DEL CPEP Swendiman RA. Deep listening. COLORRECTAL EN LAS PERSONAS MAYORES SIN CRIBAJE PREVIO?: AN\u00c1LISIS DE RENT ABILIDAD Chatterjee R, Crowley MJ, Dupre ME, Kong DF, et al. Rate - and -control therapies in patients 24887617 R/C TRATAMIENTOS PARA EL CONTROL DEL RITMO Y DE LA FRECUENCIA EN PACIENTES CON FIBRILACI\u00d3N AURICULAR: REVISI\u00d3N SISTEM\u00c1TICA Moyer VA; U.S. Preventive for cognitive older U.S. DEL USPSTF Clark AV, Ann Intern Me d 2014;160:804 -805 [AO,I] 24887619 A EDAD AVANZADA: CRIBAJE DEL C\u00c1NCER COLORRECTAL EN PERSONAS DE M\u00c1S DE 75 A\u00d1OS SIN CRIBAJES PREVIOS Kubo A, Shlager L, Marks AR, Lakritz D, Beaumont C, Gabellini K, et al. Prevention of vertical transmission of hepatitis B: an Intern Med 2014;160:828 -835 [T,I] 24862434 R/C PREVENCI\u00d3N DE LA TRANSMISI\u00d3N VERTICAL DE LA HEPATITIS B: ESTUDIO OBSERVACIONAL Bushnell C, McCullough L. Stroke prevention in women: synopsis of the 2014 American Heart LA GU\u00cdA 2014 DE LA AHA/ASA ARCHIVOS DE BRONCONEUMOLOGIA Almirall J, Blanquer J, Bello S. Neumon\u00eda adquirida en la comunidad en fumadores. Arch Bronconeumol 2014;50:250 - 254 [AO,I] 24387877 R/C NEUMON\u00cdA ADQUIRIDA EN LA COMUNIDAD EN FUMADORES ATENCION PRIMARIA Coira G, Bailon E. La invisibilidad de los cuidados que realizan las mujeres. Aten Primaria 2014;46:271 -272 [AO,I] 24947845 LA INVISIBILIDAD DE LOS CUIDADOS QUE REALIZAN LAS MUJERES Marzo -Castillejo M. El cribado de c\u00e1ncer de mama. \u00bfDebe seguir igual? Aten Primaria 2014;46:273 -275 [AO,II] 24947846 CRIBADO DE TODO IGUAL? Gorina M, Limonero JT, Pe\u00f1art X, Jim\u00e9nez J, Gass\u00f3 J. Comparaci\u00f3n de la satisfacci\u00f3n de los usuarios de atenci\u00f3n domiciliaria: modelo integrado vs. modelo dispensarizado. Aten Primaria 2014;46:276 -282 [T, II] 24768653 R/C COMPARACI\u00d3N DE LA SATISFACCI\u00d3N DE LOS USUARIOS DE ATENCI\u00d3N DOMICILIARIA: MODELO INTEGRADO VS. MODELO DISPENSARIZADO Consta\u00edn GA, Ricardo C, Rodr\u00edguez -G\u00e1zquez Mde L, Alvarez M, Mar\u00edn C, Agudelo C. Validez y utilidad diagn\u00f3stica de la escala EAT -26 para la evaluaci\u00f3n del riesgo de trastornos de la conducta alimentaria en poblaci\u00f3n femenina de Medell\u00edn, Colombia. Aten Primaria 2014;46:283 -289 [T,I] 24703389 R/C VALIDEZ Y UTILIDAD DIAGN\u00d3STICA DE LA ESCALA EAT -26 PARA LA EVALUACI\u00d3N DEL RIESGO DE TRASTORNOS DE LA CONDUCTA ALIMENTARIA EN POBLACI\u00d3N FEMENINA DE MEDELL\u00cdN, COL OMBIA Parodi N, Vill\u00e1n YF, Granados MI, Royuela A. Prescripci\u00f3n potencialmente inapropiada en mayores de 65 a\u00f1os en un centro de salud de atenci\u00f3n primaria. Aten Primaria 2014;46:290 -297 [T,I] 24661973 R/C PRESCRIPCI\u00d3N POTENCIALMENTE INAPROPIADA EN MAYORES DE 65 A\u00d1OS EN UN CENTRO DE SALUD DE ATENCI\u00d3N PRIMARIA Llauger MA, Rosas A, Burgos F, Torrente E, Tresserras R, Escarrabill J; en nombre del grupo de trabajo de espi rometr\u00eda del Plan Director de las Enfermedades del Aparato Respiratorio (PDMAR). Accesibilidad y utilizaci\u00f3n de la espirometr\u00eda en los centros de atenci\u00f3n primaria de Catalu\u00f1a. Aten Primaria 2014;46:298 -306 [T,I] 24768654 R/C ACCESIBILIDAD Y UTILIZACI\u00d3N DE LA ESPIROMETR\u00cdA EN LOS CENTROS DE ATENCI\u00d3N PRIMARIA DE CATALU\u00d1A C\u00f3rdoba R. El desaf\u00edo de los cigarrillos electr\u00f3nicos. Aten Primaria 2014;46:307 -312 [R,II] 24704194 R/C EL DESAF\u00cdO DE LOS CIGARRILLOS ELECTR\u00d3NICOS BRITISH MEDICAL JOURNAL Tammemagi MC, Lam S. Screening for S\u00c9RICA ELEVADA Dormuth CR, Fil ion KB, Paterson JM, James MT, Teare GF, Raymond CB, RIESGO DE APARICI\u00d3N DE DIABETES: ESTUDIO OBSERVACIONAL MULTIC\u00c9NTRICO SOBRE BASES DE DATOS ADMINISTRATIVAS Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, et al. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised primar y care. BMJ 2014;348:g3318 [EC,I] 24868083 R/C EFECTO DEL TRATAMIENTO CON DOSIS FIJAS COMBINADAS SOBRE EL CUMPLIMIENTO Y EL CONTROL DE FACTORES DE RIESGO EN PACIENTES CON RIESGO ALTO DE ENFERMEDAD CARDIOVASCULAR: ENSAYO CONTROLADO ALEATORIZADO EN ATENCI\u00d3N PRIMARIA Ford AC, Moayyedi ADVERTENCIAS CONTRA LA OBESIDAD Gumbinger C, Reuter B, Stock C, Sauer T, Wieth\u00f6lter H, Bruder I, et al; AG Schlaganfall. Time to with RECOMBINANTE Y RESULTADOS DEL ICTUS EN LA PR\u00c1CTICA CL\u00cdNICA: AN\u00c1LISIS RETROSPECTIVO DE DATOS DE LOS SEGUROS SOBRE CALIDAD HOSPITALARI A EN COMPARACI\u00d3N CON LOS RESULTADOS DE LOS ENSAYOS CL\u00cdNICOS ALEATORIZADOS Huffman MD. [AO,I] 24868084 DOSIS COMBINADAS DE F\u00c1RMACOS CARDIOVASCULARES Vaughan Jones S, Ambros -Rudolph C, Nelson 2014;348:g3489 [R,I] 24895225 ENFERMEDAD DE LA PIEL EN EL EMBARAZO Seow H, Brazil K, Sussman J, Pereira J, Marshall D, Austin PC, et al. Impact of community based, analysis. BMJ 2014;348:g3496 [S,I] 24906901 LOS EQUIPOS ESPECIALIZADOS DE CUIDADOS PALIATIVOS EXTRAHOSPITALARIOS SOBRE LAS HOSPITALIZACIONES Y LAS VISITAS A URGENCIAS DE ENFERMOS TERMINAL ES Y MUERTES EN EL HOSPITAL: AN\u00c1LISIS COMBINADO Maund E, Tendal B, Hr\u00f3bjartsson major disorder: comparison of clinical BMJ 2014;348:g3510 [R,I] 24899650 R/C BENEFICIOS Y PERJUICIOS EN LOS ENSAYOS CL\u00cdNICOS DE DULOXETINA PARA EL TRATAMIENTO DEL TRAS TORNO DEPRESIBO MAYOR: COMPARACI\u00d3N DE INFORMES DE ESTUDIOS CL\u00cdNICOS, REGISTROS DE ENSAYOS Y PUBLICACIONES Rueda -Clausen CF, of the stethoscope. BMJ 2014;348:g3575 [AO,I] RESULTADOS EN EL PACIENTE A AMBOS LADOS DEL ESTETOSCOPIO Doshi P, Zito J, dosReis S. 2014;348:g3578 [AO,I] 24904123 AHONDAR EN B\u00daSQUEDA DE DATOS SOBRE PERJUICIOS EN LOS ENSAYOS SOBRE DULOXETINA Lu CY, Zhang F, Lakoma MD, Madden JM, Rusinak D, Penfold RB, et al. Changes in antidepressant use by young people and suicidal behavior after FDA R/C CAMBIOS EN EL USO DE LOS ANTIDEPRESIVOS POR PARTE DE LOS J\u00d3VENES Y COMPORTAMIENTO SUICIDA TRAS LAS ADVERTENCIAS DE LA FDA Y COBERTURA POR LOS MEDIOS DE COMUNICACI\u00d3N: ESTUDIO CUASI EXPERIMENTAL Yeo B, Turner NC, Jones A. An update on the m edical management of breast cancer. BMJ 2014;348:g3608 [R,I] 24912480 ACTUALIZACI\u00d3N SOBRE EL TRATAMIENTO DEL C\u00c1NCER DE MAMA J\u00f8rgensen T, Jacobsen RK, Toft U, Aadahl M, CRIBAJE Y EL CONSEJO SOBRE H\u00c1BITOS EN LA INCIDENCIA DE ENFERMEDAD CARDIACA ISQU\u00c9MICA EN LA POBLACI\u00d3N GENERAL: ENSAYO GRIAL\" DE LOS OPIOIDES O UN F\u00c1RMACO JUSTIFICADAMENTE RECHAZADO? Jones C, Pollit V, Fitzmaurice D, Cowan C4; Guideline Group. LA BRILACI\u00d3N RESUMEN DE LA GU\u00cdA NICE ACTUALIZADA Sch\u00f6ttker B, R, Peasey A, Thorand B, Jansen Ld, al; Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES). Vitamin D and mortality: meta -analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. 24938302 R/C VITAMINA D Y MORTALIDAD: METAAN\u00c1LISIS DE DATOS DE PARTICIPANTES INDIVIDUALES DE UN GRAN CONSORCIO DE ESTUDIOS DE COHORTE DE EUROPA Y LOS ESTADOS UNIDOS G\u00f8tzsche PC, J\u00f8rgensen LOS EX\u00c1MENES GENERALES SALUD NO FUNCIONAN Murtagh F. Can palliative care teams relieve some [AO,I] 24906714 \u00bfPUEDEN LOS EQUIPOS DE CUIDADOS PALIATIVOS ALIVIAR ALGO DE LA PRESI\u00d3N SOBRE LOS SERVICIOS DE AGUDOS? Boyd K, Murray SA. Why is talking about a challenge? BMJ 2014;348:g3699 [AO, I] 24906715 -Fekj\u00e6r MAMOGR\u00c1FICO LA POR C\u00c1NCER DE MAMA: ESTUDIO POBLACIONAL Greenhalgh T, Howick J, Maskrey N; Evidence ed Sj\u00f6lander A, Runeson B, D'Onofrio BM, Lichtenstein P, Larsson H. Drug treatment DE ATENCI\u00d3N Y COMPOR TAMIENTO SUICIDA: ESTUDIO BASADO EN REGISTROS Elmore JG, Harris RP. The harms and benefits of modern screening mammography. et EN PACIENTES CON ENFERMEDAD ARTERIAL CORONARIA ESTABLE: METAAN\u00c1LISIS EN RED Rees J, Bultitud M, Challacombe B. The management of lower tract symptoms in men. BMJ 2014 ;348:g3861 [R,II] R/C MANEJO DE LOS S\u00cdNTOMAS DE V\u00cdAS URINATIAS BAJAS EN HOMBRES Sridhar D, Frenk J, Gostin L, Moon S. Global rules for global health: why we need an independent, impartial WHO. BMJ 2014;348:g3841 [AO,I] 24942299 REGLAS MUNDIALES PARA LA SALUD MUNDIAL: POR QU\u00c9 NECESITAMOS UNA OMS INDEPENDIENTE E IMPARCIAL McCartney M. How to undermine general practice. BMJ 2014;348:g4061 [AO,I] 24934620 C\u00d3MO MINAR GENERAL A, Nundy [AO,I] 24965786 CORRUPCI\u00d3N: EL SUCIO SECRETO ABIERTO DE LA MEDICINA BRITISH JOURNAL OF PSYCHIATRY Orrell M, Aguirre E, Spector A, Hoare Z, Woods RT, Streater A, et ESTIMULACI\u00d3N COGNITIVA EN LA DEMENCIA: ENSAYO CONTROLADO ALEATORIZADO PRAGM\u00c1TICO A DOBLE CIEGO MULTIC\u00c9NTRICO Mayou R. Is the DSM -5 chapter on \u00bfES EL CAP\u00cdTULO DEL DSM -5 SOBRE TRASTORNO DE S\u00cdNTOMAS SOM\u00c1TICOS MEJOR DE ALGUNA MANERA QUE EL TRASTORNO SOMATOFORME DEL DSM -IV? D'Amico F, Knapp M, Beecham J, Sandberg S, Taylor E, Sayal K. Use of services and associated costs for young with [S,II] 24676966 R/C USO DE SERVICIOS Y SUS COSTES ASOCIADOS POR PARTE DE J\u00d3VENES CON PROBLEMAS DE CONDUCTA E HIPERACTIVIDAD EN LA INFANCIA: 2 0 A\u00d1OS DE SEGUIMIENTO Qin P, Hawton K, Mortensen PB, Webb R. Combined effects of physical illness and comorbid psychiatric disorder on risk of suicide in national 24578445 EFECTOS COMBINADOS DE ENFERMEDAD F\u00cdSICA Y TRASTORNO PSIQUI\u00c1TRICO COM\u00d3RBIDO SOBRE EL RIESGO DE SUICIDIO DENTRO DE UN ESTUDIO POBLACIONAL NACIONAL Vicens C, Bejarano F, Sempere E, Mateu C, Fiol F, Socias I, et al. Comparative efficacy of two to discontinue 24526745 R/C EFICACIA COMPARADA DE DOS INTERVENCIONES PARA DETENER EL USO DE BENZODIACEPINAS A LARGO PLAZO: ENSAYO CONTROLADO ALEATORIZADO POR GRUPOS EN ATENCI\u00d3N PRIMARIA CANADIAN MEDICAL ASSOCIATION JOURNAL Giddings G. Measles vaccination: a shot [AO,I] 24863920 VACUNA DEL SARAMPI\u00d3N: UN DISPARO COM\u00daN Caro -Bruce E, Flaxman CMAJ 2014;186:694 [AO,I] 24591280 ANAFILAXIA EN EL DE ATENCI\u00d3N AGUDA Dixon A, Clarkin C, Barrowman N, Correll R, Osmond MH, Plint AC. of radial -head in children nurses LA SUBLUXACI\u00d3N DE LA CABEZA DEL RADIO EN NI\u00d1OS POR LAS ENFERMERAS DE TRIAJE EN EL SERVICIO DE URGENCIAS: ENSAYO CONTROLADO ALEATORIZADO POR GRUPOS Afifi TO, MacMillan HL, Boyle M, Taillieu T, Cheung K, Sareen J. Child -E332 [T,I] 24756625 R/C Y TRASTORNOS MENTALES EN CANAD\u00c1 Kennedy SA, Baerlocher MO. New and experimental approaches to back pain. CMAJ 2014;186:E340 [AO,I] 24516088 ABORDAJES RECEPTOR GLP -1 PARA LA DIABETES M ELLITUS: PAPEL EN LA ENFERMEDAD CARDIOVASCULAR Wong CX, Lau DH, Sanders P. Atrial fibrillation epidemic A, Pant S, al. Contemporary trends of hospitalization for atrial in FIBRILACI\u00d3N AURIC ULAR EN LOS EE UU, DE 2000 A 2010: IMPLICACIONES PARA LA PLANIFICACI\u00d3N DE LA ATENCI\u00d3N SANITARIA Zaman S, Kovoor P. Sudden cardiac MIOCARDIO: PATOG\u00c9NESIS, ESTRATIFICACI\u00d3N DEL RIESGO Y -2573 [R,I] 24934464 MANEJO GLUC\u00c9MICO EN PACIENTES CON ENFERMEDAD ARTERIAL CORONARI A Y PREDIABETES O DIABETES MELLITUS TIPO 2 Menon V, Lincoff AM. Cardiovascular safety evaluation in the development of new drugs for diabetes mellitus. Circulation 2014;129:2705 -2713 [R,II] 24958 753 EVALUACI\u00d3N DE LA SEGURIDAD CARDIOVASCULAR EN EL DESARROLLO DE NUEVOS F\u00c1RMACOS PARA LA DIABETES MELLITUS Antman EM, Appel LJ, Balentine D, Johnson RK, Steffen LM, in the food supply: a conference report from the american heart association sodium 2013 planning group. Circulation 2014;129:e660 -e679 Bretzel RG, Del Prato S, in people with type 2 Care 2014;37:1499 -1508 [R,I] 24855154 R/C TRATAMIENTO C ON INSULINA DIABETES TIPO 2: \u00bfOPORTUNIDADES Y RETOS? Feig LL. and serious perinatal outcomes: a large, population -based -1596 [S,I] 24705609 R/C TENDENCIAS EN LA INCIDENCIA DE DIABETES EN EL EMBARAZO Y RESULTADOS PERINATALES GRAVES: ESTUDIO POBLACIONAL EXTENSO EN ONTARIO, CANAD\u00c1, DE 1996 A 2010 Laxy M, Mielck A, Hunger M, Schunk M, Meisinger C, R\u00fcckert IM, et al. The association patient self management behavior, intermediate clinical 2 diabetes: results from study. [S,II] 24667462 R/C ASOCIACI\u00d3N ENTRE AUTOMANEJO INFORMADO POR EL PACIENTE, RESULTADOS CL\u00cdNICOS INTERMEDIOS Y MORTALIDAD EN PACIENTES CON DIABETES TIPO 2: RESULTADOS DEL ESTUDIO KORA -A H\u00e4ring HU, 2 24 -week, randomized, double -blind, placebo EN PACIENTES CON DIABETES TIPO 2: ENSAYO DE 24 SEMANAS ALEATORIZADO DOBLE CIEGO CONTROLADO CON PLACEBO Waaijman R, de Haart M, Arts ML, Wever D, Verlouw AJ, Nollet F, al. DE RIESGO PARA LA RECURRENCIA DE LA \u00daLCERA PLANTAR DEL PIE EN PACIE NTES CON Cushman WC, et al. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: 2014;37:1721 -1728 [EC,II] 24595629 R/C RESULTADOS DE LAS ESTRATEGIAS COMBINADAS DE MANEJO DE LOS FACTORES DE RIESGO CARDIOVASCULAR EN LA DIABETES TIPO 2: ENSAYO ALEATORIZADO ACCORD Pal K, Eastwood SV, Michie S, Farmer A, Barnard ML, Peacock R, et al. Computer -based interventions to improve self - management in adults with type 2 diabetes: a systematic R/C INTERVENCIONES MEDIANTE ORDENADOR PARA MEJORAR EL AUTOMANEJO EN ADULTOS CON DIABETES TIPO 2: REVISI\u00d3N SISTEM\u00c1TICA Y Grunberger G. Davidson MB. Insulin analogs -is there 24855160 R/C \u00bfHAY UNA RAZ\u00d3N CONVINCENTE AN\u00c1LOGOS DE LA INSULINA? \u00a1NO! DRUGS Alsultan A, - 854 [R,II] 24846578 R/C MONITORIZACI\u00d3N TERAP\u00c9UTICA DE LOS F\u00c1RMACOS EN EL TRATAMIENTO DE LA TUBERCULOSIS: ACTUALIZACI\u00d3N Bschor T. Lithium in the 2014;74:855 -862 [R,I] 24825489 DEPRESIVO MAYOR Hilgenfeld R, Seipke G, Berchtold H, Owens DR. The evolution of insulin EVOLUCI\u00d3N DE LA INSULINA GLARGINA Y SU CONTINUA CONTRIBUCI\u00d3N A LA ATENCI\u00d3N A LA DIABETES Bichoupan K, Dieterich DT. Hepatitis C in VIH: IMPACTO DE LOS ANTIV\u00cdRICOS DIRECTOS Chrusciel P, Rysz J, Banach M. Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role LA TRIMETAZIDINA EN EL TRATAMIENTO DE LOS TRASTORNOS CARDIOVASCULARES: ALGUNAS REFLEXIONES SOBRE SU PAPEL EN LA INSUFI CIENCIA CARDIACA Y LA ENFERMEDAD ARTERIAL PERIF\u00c9RICA EUROPEAN HEART JOU RNAL Arnold SV, Spertus JA, Nallamothu The hostile heart: anger as a trigger for cardiovascular events. Eur Heart J 2014;35:1359 -1360 [AO,I] 24591549 EL CORAZ\u00d3N HOSTIL: LA IRA COMO DE ACONTECIMIENTOS CARDIOVASCULARES AGUDOS Della Rocca DG, Pepine CJ. Some thoughts on Heart J 2014;35:1361 - 1364 [AO,I] 23045268 ALGUNOS PENSAMIENTOS SOBRE EL CONTINUO DILEMA DE LA ANGINA DE PECHO Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J 2014;35:1365 -1372 Bjerkeset and depression and risk of acute myocardial infarction: the HUNT 2 study. -1403 [S,II] 2405707 7 R/C S\u00cdNTO MAS DE ANSIEDAD Y DEPRESI\u00d3N Y RIESGO DE INFARTO AGUDO DE MIOCARDIO: ESTUDIO HUNT 2 Mostofsky E, Penner EA, Mittleman MA. Outbursts of anger as a trigger of acute cardiovascular events: a systematic review -1410 24591550 DE IRA COMO DESENCADENANTE DE ACONTECIMIENOTOS AGUDOS CARDIOVASCULARES: REVISI\u00d3N SISTEM\u00c1TICA Y METAAN\u00c1LISIS Connolly SJ. Real -world experience with atrial fibrillation J 2014;35:1430 -1432 [AO,I] 24468887 EXPERIENCIA EN EL MUNDO REAL CON LA ABLACI\u00d3N EN LA FIBRILACI\u00d3N AURICULAR: CAUSA DE PREOCUPACI\u00d3N Wasmer K, The young patient with asymptomatic atrial fibrillation: what is the evidence to Eur Heart J 2014;35:1439 LA EVIDENCIA PARA TRATAR? Nattel S, Guasch E, Savelieva I, Cosio FG, Valverde Halperin JL, et al. Early management of atrial fibrillation MANEJO PRECOZ DE LA FIBRILACI\u00d3N AURICULAR PARA PREVENIR LAS COMPLICACIONES CARDIOVASCULARES FAMILY MEDICINE Willis DR, Bennett I, Jones BG, Renshaw SE, Holley M, Dankoski ME. Practice -based learning and improvement in family medicine student clerkships: a CERA study. Fam Med 2014;46:423 -428 [T,II] 24911296 R/C APRENDIZAJE BASADO EN LA PR\u00c1 CTICA Y MEJOR\u00cdA DE LAS ROTACIONES DE LOS ESTUDIANTES EN MEDICINA DE FAMILIA: ESTUDIO CERA Taylor JS, George PF, MacNamara MM, Zink D, Patel NK, Gainor J, et al. A new R/C NUEVA ROTACI\u00d3N SOBRE HABILIDADES CL\u00cdNICAS PARA ESTUDIANTES DE MEDICINA Collins L, Sato R, LaNoue M, Michaluk L, Verma 24911299 R/C IMPACTO DE UN CURR\u00cdCULO DE ROTACI\u00d3N CENTRADA EN EL PACI ENTE Ringoir depression R/C BETA -BLOQUEANTES Y DEPRESI\u00d3N EN PACIENTES ANCIANOS CON HIPERTENSI\u00d3N EN ATENCI\u00d3N PRIMARIA FAMILY PRACTICE Solberg LI. Patient EL PACIENTE \u00bfLA PR\u00d3XIMA RESPUESTA PROMETEDORA? Unverzagt S, Oem ler M, Braun K, Klement A. for guideline implementation in [M,II] 24367069 R/C ESTRATEGIAS PARA LA PUESTA EN MARCHA DE GU\u00cdAS EN ATENCI\u00d3N PRIMARIA CENTRADAS EN LOS PACIENTES CON ENFERMEDAD CARDIOVASCULAR: REVISI\u00d3N SISTEM\u00c1TICA van der Zwaard BC, Poppe E, Vanwanseele B, van der Horst R/C DESARROLLO Y EVALUACI\u00d3N DE UN FOLLETO CON CONSEJOS PARA LOS PIES: ENSAYO CONTROLADO ALEATORIZADO Boffin N, Moreels S, Vanthomme Casteren EN PACIENTES ANCIANOS EN MEDICINA GENERAL: ESTUDIO DE VIGILANCIA DURANTE 2 A\u00d1OS Fitzmaurice DA, McCahon D, Baker J, Murray ET, Jowett S, Sandhar H, et al. Is screening for AF worthwhile? Stroke risk in a A FIBRILACI\u00d3N AURICULAR ? RIESGO DE ICTUS EN UNA POBLACI\u00d3N CRIBADA DEL ESTUDIO SAFE G\u00f6rig T, Mayer M, Bock C, Diehl K, Hilger J, Herr RM, et al. CONSEJO DIET\u00c9TICO PARA LA PREVENCI\u00d3N DE LA ENFERMEDAD CARDIOVASCULAR EN EL \u00c1MBITO DE LA ATENCI\u00d3N PRIMARIA: RESULTADOS DE UNA ENCUESTA EN M\u00c9DICOS ALEMANES Stijnen MM, Y BIENESTAR DETECTADOS SIGUIENDO UNA VALOR ACI\u00d3N GERI\u00c1TRICA INTEGRAL DURANTE LA VISITA DOMICILIARIA EN PERSONAS MAYORES QUE VIVEN EN LA COMUNIDAD: \u00bfQUI\u00c9N SE BENEFICIA M\u00c1S? Furler JS, Blackberry ID, Walker C, Manski -Nankervis JA, Anderson J, O'Neal D, et al. Stepping up: a nurse -led model of care f or insulin initiation for people with type 2 diabetes. -356 [C,I] 24473676 R/C UN PASO ADELANTE: MODELO DE ATENCI\u00d3N DIRIGIDO POR ENFERMERAS PARA LA INICIACI\u00d3N EN LA INSULINA DE PERSONAS CON DIABETES TIPO 2 Bishop FL, Howick J, Heneghan C, Stevens S, Hobbs FD, Lewith the exploring GPs' USO DE PLACEBO EN RU: ESTUDIO CUALITATIVO PARA EXPLORAR LOS PUNTOS DE VISTA DE LOS M\u00c9DICOS GENERALES SOBRE LOS EFECTOS PLACEBO EN LA PR\u00c1CTICA CL\u00cdNI CA Jenkinson CE, Winder RE, Sugg HV, Roberts MJ, Ridgway N, Kuyken W, et al. Why do GPs exclude patients from participating in research? An exploration of \u00bfPOR QU\u00c9 EXCLUYEN LOS M\u00c9DICOS GENERALES A PACIENTES DE LA PARTICIPACI\u00d3N EN LA INVESTIGACI\u00d3N? EXPLORACI\u00d3N DEL SEGUIMIENTO Y DE LA DISCREPANCIA DE LOS CRITERIOS DE LOS ENSAYOS JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION Mortensen EM, Halm EA, Pugh MJ, Copeland LA, Metersky M, Fine MJ, et al. Association of azithromycin with CARDIOVASCULARES ENTRE PACIENTES MAYORES EN PACIENTES CON FRACCI\u00d3N DE EYE CCI\u00d3N VENTRICULAR IZQUIERDA ENTRE 30 Y 35 % Salt restriction. JAMA 2014;311:2229 [AO,I] 24893092 RESTRICCI\u00d3N DE SAL diabetes. JAMA 2014;311:2267 DE DIABETES Jampol LM, Bressler NM, Glassman AR. Revolution to a new of diabetic macular edema. JAMA 2014;311:2269 -2270 [AO,I] 24915254 REVOLUCI\u00d3N HACIA UN NUEVO EST\u00c1NDAR DE TRATAMIENTO DEL EDEMA MACULAR DIAB\u00c9TICO Sacks DB, HEMOGLOBINA A1C Roumie CL, Greevy RA, Grijalva CG, Hung AM, Liu X, Murff HJ, et al. Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and ASOCIACI\u00d3N ENTRE INTENSIFICACI\u00d3N DEL TRATAMIENTO DE METFORMINA CON INSULINA FRENTE A SULFONILUREAS Y ACONTECIMIENTOS CARDIOVASCULARES Y MORTALIDAD POR CUALQUIER CAUSA ENTRE PACIENTES CON DIABETES Wallia A, Molitch ME. Insulin therapy for 2014;311:2315 -2325 [M,II] 24915263 R/C TERAPIA CON INSULINA EN LA DIABETES MELLITUS TIPO 2 Andrews MA, O'Malley PG. Diabetes overtreatment in elderly i ndividuals: risky business of better management. JAMA 2014;311:2326 -2327 [AO,I] 24915264 SOBRETRATAMIENTO DE LA DIABETES EN LAS PERSONAS MAYORES: ASUNTO ARRIESGADO QUE REQUIERE UN MANEJO MEJOR Beckman Turin TC, Matsushita K, Sang Y, Ba llew SH, Appel LJ, et R/C CA\u00cdDA EN LA TASA DE FLUJO GLOMERULAR ESTIMADA Y RIESGO POSTERIOR DE ENFERMEDAD RENAL TERMINAL Y MORTALIDAD Pahor M, Guralnik JM, Ambrosius WT, Blair S, Bonds DE, TS, al; LIFE study investigators. Effect of structured physical of in [EC,II] 24866862 R/C EFECTO DE LA ACTIVIDAD F\u00cdSICA ESTRUCTURADA SOBRE LA PREVENCI\u00d3N DE DISCAPACIDAD IMPORTANTE DE LA MOVILIDAD EN ANCIANOS: ENSAYO CL\u00cdNICO ALEATORIZADO ESTUDIO LIFE Cooney G, Dwan K, depression. JAMA 2014;311:2432 -2433 [AO,II] 24938566 R/C EJERCICIO LA DEPRESI\u00d3N Ludwig Friedman MI. Increasing adiposity: consequence or cause of AUMENTO DE O DE COMIDA? W. Resistant hypertension: 24893089 ENTE: Richardson Lipsky BA. PA A LA MAMOGRAF\u00cdA DIGITAL? Friedewald SM, Rafferty EA, Rose SL, Durand MA, Greenberg JS, et al. Breast cancer CRIBAJE C\u00c1NCER DE USANDO TOMOS\u00cdNTESIS EN COMBINACI\u00d3N CON MAMOGRAF\u00cdA DIGITAL JAMA INTERNAL MEDICINE Foy Ting PERIOPERATORIO INNECESARIO: MOMENTO DE APRENDIZAJE Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of R/C REDUCCI\u00d3N DE PRESCRIPCIONES INADECUADAS DE BENZODIACEPINAS ENTRE ANCIANOS A TRAV\u00c9S DE LA EDUCACI\u00d3N DIRECTA DEL PACIENTE: ENSAYO ALEATORIZADO AGRUPADO EMPOW ER Huffman JC, CM, DuBois CM, Healy BC, et al. Collaborative care in patients with recent cardiac events: and in [EC,I] 24733277 R/C ATENCI\u00d3N COORDINADA A LA DEPRESI\u00d3N Y LOS TRASTORNOS D E ANSIEDAD EN PACIENTES CON ACO NTECIMIENTOS CARDIACOS RECIENTES: ENSAYO CL \u00cdNICO ALEATO RIZADO Fryback DG, Hammond CS, Hanna LG, Grove MR, Brown M, et al. Consequences of false [S,I] MAMOGRAF\u00cdAS DE CRIBAJE Li WQ, Qureshi AA, Robinson KC, Han J. Sildenafil use and increased risk of incident melanoma in US men: a 24710960 R/C USO DE SILDENAFILO Y AUMENTO DEL RIESGO DE MELANOMA EN HOMBRES ESTADOUNIDENSES: ESTUDIO DE COHORTE PROSPECTIVO JAMA PSYCHIATRY Correll CU, Efficacy of pharmacologic psychotherapeutic interventions in psychiatry: to talk or question? JAMA Psychiatry 2014;71:624 PSIQUIATR\u00cdA: HABLAR O PRESCRIBIR R/C EFICACIA DE LA FARMACOTERAPIA Y LA PSICOTERAPIA EN LOS TRASTORNOS PSIQUI\u00c1TRICOS DEL ADULTO: RESUMEN SISTEM\u00c1TICO DE METAAN\u00c1LISIS MEDICINA CLINICA Gonz\u00e1lez -Molero I, Rojo G, Morcillo S, P\u00e9rez -Valero V, Rubio -Mart\u00edn E, Gutierrez -Repiso C, Soriguer F. Relaci\u00f3n entre d\u00e9ficit de vitamina D y s\u00edndrome metab\u00f3lico. Med Clin (Barc) 2014;142:473 -477 [S,II] 24216018 R/C RELACI\u00d3N ENTRE VITAMINA D Y S\u00cdNDROME METAB\u00d3LICO Gonz\u00e1lez -Clemente JM, Font B, Lahoz R, Llaurad\u00f3 G, Gamb\u00fas G; Grupo de investigadores del Estudio INERCIA. Inercia cl\u00ednica en pacientes con diabetes mellitus tipo 2 no insuliniz ados en tratamiento con hipoglucemiantes 2014;142:478 -484 R/C INERCIA CL\u00cdNICA CON DIABETES MELLIT US TIPO 2 NO INSULINIZADOS EN TRATAMIENTO CON HIPOGLUCEMIANTES ORALES. ESTUDIO INERCIA Gomis R, Artola S, Conthe P, Vidal J, Casamor R, Font B; investigadores del Grupo de Estudio OBEDIA. Prevalencia de diabetes mellitus tipo 2 en pacientes ambulatorios c on sobrepeso u obesidad en Espa\u00f1a. Estudio OBEDIA. Med Clin (Barc) 2014;142:485 -492 [T,II] 23683969 DIABETES MELLITUS TIPO 2 EN PACIENTES AMBULATORI OS CON SOBREPESO U OBESIDAD EN ESPA\u00d1A. ESTUDIO OBEDIA Gonz\u00e1lez -Parra E, Egido J. Vitamina D, s\u00edndrome metab\u00f3lico diabetes mellitus. Med Clin (Barc) 2014;142:493 -496 [AO,I] 24629694 VITAMINA D, S\u00cdNDROME METAB\u00d3LICO Y DIABETES MELLITUS Lim\u00f3n -Ram\u00edrez R, Gea -Vel\u00e1zquez de Castro MT, Aranaz -Andr\u00e9s JM. Dise\u00f1o de una estrategia multimodal incluyendo marketing sanitario para la mejora del cumplimiento de la higiene de manos. Med Clin (Barc) 2014;142:505 -511 [R,I] 24387954 DISE\u00d1O DE UNA ESTRATEGIA MULTIMODAL INCLUYENDO MARKETING SANITARIO PARA LA MEJORA DEL CUMPLIMIENTO DE LA HIGIENE DE MANOS Morillas RM, Sala M, Planas R. Profilaxis de Faro M, S\u00e1ez -Franc\u00e0s N, Castro -Marrero J, Aliste L, Col lado A, Alegre J. Impacto de la fibromialgia en el s\u00edndrome de fatiga cr\u00f3nica. Med Clin -525 [T,I] 24387955 R/C IMPACTO DE S\u00cdNDROME DE FATIGA CR\u00d3NICA Mart\u00edn -Ramiro JJ, Alvarez -Mart\u00edn E, Gil -Prieto R. Mortalidad atribuible al exceso de peso en Espa\u00f1a. Med Clin (Barc) 2014;142:526 -530 [T,II] 24183117 R/C MORTALIDAD Rico-Villademoros F, Calandre (Barc) 2014;142:540 -541 [AO,I] A 30 A\u00d1OS? Catal\u00e1 -L\u00f3pez F, Hutton B, Moher D. Declaraci\u00f3n de transparencia para las publicaciones cient\u00edficas. Med Clin (Barc) 2014;142:554 -555 [AO,II] 24703420 DECLARACI\u00d3N DE TRANSPARENCIA PARA LAS PUBLICACIONES CIENT\u00cdFICAS REVISTA ESPA\u00d1OLA DE CARDIOLOGIA Ferreira -Gonz\u00e1lez I. Bases para la interpretaci\u00f3n de los estudios de no inferioridad: a prop\u00f3sito de los estudios ROCKET -AF, RE 24863590 R/C BASES PARA LA INTERPRETACI\u00d3N DE LOS ESTUDIOS DE NO INFERIORIDAD: A PROP\u00d3SITO DE LOS ESTUDIOS ROCKET -AF, RE -LY Y ARISTOTLE Vald\u00e9s S, Garc\u00eda -Torres F, Maldonado -Araque C, Goday A, Calle -Pascual A, Soriguer F, et al; Di@bet.es st udy group. Prevalencia de obesidad, diabetes mellitus y otros factores de riesgo cardiovascular en Andaluc\u00eda. Comparaci\u00f3n con datos de prevalencia nacionales. Estudio Di@bet.es. Rev Esp Cardiol 2014;67:442 -448 [T,I] 24863592 R/C PREVALENCIA DE OBESIDAD, DIABETES MELLITUS Y OTROS FACTORES DE RIESGO CARDIOVASCULAR EN ANDALUC\u00cdA. COMPARACI\u00d3N CON DATOS DE PREVALENCIA NACIONALES. ESTUDIO DI@BET.ES Gurbel PA, Rafeedheen R, Tantry Salt: a taste of 2014;32:62 -66 [T,I] 24779455 R/C M\u00c9TODO PARA LA DETECCI\u00d3N DOMICILIARIA DE TOLERANCIA ALTERADA A LA GLUCOSA EN PACIENTES HIPERTENSOS EN ATENCI\u00d3N PRIMARIA Kujanp\u00e4\u00e4 T, Ylisaukko -Oja T, Jokelainen Hirsikangas Finnish translation of GAD -7 and GAD -2 screening tools. Scand J Prim Health Care 2014;32:78 -83 [T,I] 24920316 R/C PREVALENCIA DE TRASTORNOS DE ANSIEDAD ENTRE HIPERUTILIZADORES FINESES DE ATENCI\u00d3N PRIMARIA Y VALIDACI\u00d3N DE LA TRADUCCI\u00d3N FINESA DE LAS HERRAMIENTAS DE CRIBAJE GAD -7 Y GAD -2 Nevalainen M, Kuikka among young and experienced GPs. J Prim Health Care 2014;32:84 -89 [T,II] 24914458 R/C ERRORES M\u00c9DICOS E INCERTIDUMBRE EN ATENCI\u00d3N PRIMARIA DE SALUD: ESTUDIO COMPARATIVO DE ESTRATEGIAS DE SUPERACI\u00d3N ENTRE M\u00c9DICOS GENERALES TANTO J\u00d3VENES COMO EXPERIMENTADOS Koffeman AR, Valkhoff VE, Jong GW, Warl\u00e9 -van PJ, M C, risk and prescription non -steroidal anti -inflammatory for [S,I] 24931511 R/C RIESGO CARDIOVASCULAR ISQU\u00c9MICO Y PRESCRIPCI\u00d3N DE AINE PARA LAS MOLESTIAS OSTEOMUSCULARES THE LANCET Hypertension: an urgent need for global control and prevention. Lancet 2014;383:1861 [AO,I] 24881973 HIPERTENSI\u00d3N: NECESIDAD URGENTE DE CONTROL Y PREVENCI\u00d3N MUNDIALES Polio eradication: the CIA and their unintended victims. Lancet 2014;383:1862 [AO,I] 24881975 ERRADICACI\u00d3N DE LA POLIO: C\u00cdA Y SUS V\u00cdCTIMAS NO INTENCIONADAS Waeber B, Feihl F. Y VALSARTAN: TRATAMIENTO \u00daTIL PARA LA HIPERTENSI\u00d3N Kahan T. Focus on blood pressure as a major risk factor. Lancet 2014;383:1866 -1868.[AO,I] 24881978 CONCENTRARSE EN LA TENSI\u00d3N ARTERIAL COMO FACTOR DE RIESGO DE PRIMER ORDEN McManus RJ, Mant J. The drugs do Lancet 2014;383:1868 -1869 [AO,I] 24881979 LAS MEDICINAS FUNCIONAN: MEJOR\u00cdA DE LA TEN SI\u00d3N ARTERIAL EN INGLATERRA Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, et al; NAC -MD-01 Study Investigators. Efficacy and safety of nebivolol fixed SEGURIDAD DEL NEBIVOLOL Y EL VALSART AN COMO COMBINACI\u00d3N A DOSIS FIJA EN LA HIPERTENSI\u00d3N: ESTUDIO ALEATORIZADO MULTIC\u00c9NTRICO Rapsomaniki E, Timmis A, George J, Pujades -Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, 2014;383:1899 -1911 [S,II] R/C TENSI\u00d3N ARTERIAL E INCIDENCIA DE DOCE ENFERMEDADES CARDIOVASCULARES: RIESGOS A LO LARGO DE LA VIDA, A\u00d1OS DE VIDA SANA PERDIDOS Y ASOCIACIONES ESPEC\u00cdFICAS POR EDAD EN 1,25 MILLONES DE PERSONAS Falaschetti E, Mindell J, Knott C, Poulter N. Hypertension management in England: a serial cross -sectional study from 1994 to 2011. Lancet 2014;383:1912 -1919 [T,I] 24881995 R/C MANEJO DE LA HIPERTENSI\u00d3N EN INGLATERRA: ESTUDIO TRANSVERSAL SERIADO DESDE 1994 A 2011 Back to basics for diabetes. Lancet 2014;383:1945 [AO,I] 24910218 VUELTA A LOS PRINCIPIOS EN LA DIABETES Shi Y, Hu FB. The global implications of diabetes and cancer. Lancet 2014;383:1947 -1948 [AO,I] 24910221 IMPLICACIONES MUNDIALES DE LA DIABETES Y EL C\u00c1NCER Ji L. Sex disparity in the risk of diabetes -associated stroke. Lancet 2014;383:1948 -1950 [AO,I] 24613027 DISPARIDAD ENTRE SEXOS EN EL RIESGO DE ICTUS ASOCIADO A LA DIABETES Peters SA, Huxley RR, W oodward M. Diabetes as a risk factor for stroke in women compared with men: a DIABETES COMO FACTOR DE RIESGO PARA EL ICTUS EN MUJERES COMPARADAS CON HOMBRES: REVISI\u00d3N SISTEM\u00c1TICA Y METAAN\u00c1LISIS DE 64 COHORTES QUE INCLUYEN A 775.385 INDIVIDUOS Y 12.539 ICTUS Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, A\u00efssi D, Wahl S, et methylation E CORPORAL: AN\u00c1LISIS GEN\u00d3MICO AMPLIO Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and Y MANEJO DE LA DIABETES TIPO 2: COMPONENTES DIET\u00c9TICOS Y ESTRATEGIAS NUTRICIONALES The World (fizzy drink) Cup 2014. Lancet 2014;383:2020 [AO,I] 24931680 LA COPA MUNDIAL 2014 (DE BEBIDA GASEOSA) Migliori GB, Sotgiu G. Measuring the effect Lancet 2014;383:2026 -2028 [AO,I] 24650956 MEDIR EL EFECTO DEL CONTROL DE LA TUBERCULOSIS: UN PASO ADELANTE THE NEW ENGLAND JOURNAL OF MEDICINE Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das 24897082 R/C DALBAVACINA UNA VEZ A LA SEMANA FRENTE AL TRATAMIENTO DIARIO CONVENCIONAL PARA LAS INFECCIONES DE LA PIEL Corey GR, Kabler H, Mehra P, Gupta Single oritavancin in the treatment of acute 24897083 R/C ORITAVACINA EN DOSIS SIMPLE EN EL TRATAMIENTO DE LAS INFECCIONES D\u00c9RMICAS AGUDAS BACTERIANAS Chirinos JA, Gurubhagavatula I, Teff K, Rade r DJ, Wadden TA, Townsend R, et al. CPAP, weight loss, or both for 2014;370:2265 -2275 [EC,I] 24918371 R/C CPAP, P\u00c9RDIDA DE PESO O AMBAS EN LA APNEA OBSTRUCTIVA DEL SUE\u00d1O Gottlieb DJ, Punjabi NM, Mehra R, Patel SR, Quan SF, Babineau DC, et al. CPAP versus oxygen in [EC,I] R/C CPAP APNEA OBSTRUCTIVA DEL SUE\u00d1O Ingelfinger JR. Clinical practice. The child or adolescent with elevated blood pressure. N Engl J Med 2014;370:2316 - 2325 [R,I] 24918374 PR\u00c1CTICA CL\u00cdNICA. EL NI\u00d1O O ADOLESCENTE CON TENSI\u00d3N ARTERIAL ELEVADA Macaraig M, Burzynski J, Varma JK. Tuberculosis control in New York City --a changing landscape. N Engl J Med 2014;370:2362 -2365 [AO,I] 24941176 CONTROL DE LA TUBERCULOSIS EN LA CIUDAD DE NUEVA YORK -UN PAISAJE CAMBIANTE Hoberman A, Greenfield SP, Mattoo TK, Keren -2376 Chey WD, Webster L, Sostek M, DOLOR NO ONCOL\u00d3GICO Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, et al. Antidepressant use in pregnancy and the risk 2014;370:2397 -2407 [S,II] 24941178 R/C USO DE ANTIDEPRESIVOS EN EL EMBARAZO Y RIESGO DE DEFECTOS CARDIACOS Biesecker LG, Green RC. Diagnostic ANTIBI\u00d3TICA EL REFLUJO VESICOURETERAL --RESPUESTAS, PERO TODAV\u00cdA PREGUNTAS Hwang TJ, Bourgeois FT, Seeger JD. Drug safety in the digital age. N Engl J Med 2014;370:2460 -2462 [AO,I] 24963564 SEGURIDAD 24963570 PROFILAXIS CONTRA EL TROMBOEMBOLISMO VENOSO EN PACIENTES AMBULATORIOS CON C\u00c1NCER Cardiovascular morbidity and obstructive sleep apnea. N Engl print] S24662199 All physicians take a -some in their practices and communities as informal leaders, and others hold formal leadership roles to which they are appointed or elected. These formal leadership roles c onvey power those individuals who hold such positions. Formal leadership, however, is limited in its influence unless it is accompanied b y a series of personal and interpersonal competencies that characterize both formal and informal leaders.Many physic ians who do not hold formal leadership roles will be called on to provide (or will wish to provide) informal leadership at various times in their careers . Both formal and informal leaders should be trained personal and interpersonal author defines leadership and describes the characteristics of formal and informal leaders, then discusse s the types of leadership and the power derived from different leadership roles. He concludes by arguing in favor of expanding the scope of leadership training policies progr ams designed to assess risk of poor physic ian and transmission of HBV. A negative e antigen status or a viral load less than 5 \u00d7 IU/mL (90.9% of women at extremely low risk for tra nsmission after immunoprophylaxis who are to benefit This factors for stroke and suggests well beyond age 75 years. A colonoscopy is indicated at most ages. S24663815 The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for c ognitive impairment. (I statement). ARCHIVOS DE BRONCONEUMOLOGIA S24387877 En estudios recientes ha quedando quedado perfectamente establecido que el tabaco incrementa la susceptibilidad a la infecci\u00f3n bacteriana pulmonar, incluso en fumadores pasivos. Este efecto muestra tambi\u00e9n dosis -respuesta, ya que disminuye espectacularmente el riesgo 10 a\u00f1os despu\u00e9s de abandonar e l h\u00e1bito tab\u00e1quico, situ\u00e1ndose a niveles de no fumadores. Streptococcus pneumoniae es el microorganismo causante de neumon\u00eda adquirida en la comunidad (NAC) que m\u00e1s se ha relacionado con el tabaquismo, especialmente en situaciones de enfermedad neumoc\u00f3cica invasiva y shock s\u00e9ptico. Su influencia sobre la evoluci\u00f3n de la neumon\u00eda no parece clara, aunque existen evidencias que sugieren un peor pron\u00f3stico de la neumon\u00eda neumoc\u00f3cica. En NAC causadas por Legionella pneumophila tambi\u00e9n se ha observado que el h\u00e1bi to tab\u00e1quico es el factor de riesgo m\u00e1s remarcable, ya que puede suponer un aumento del riesgo del 121% por cada paquete diario de cigarrillos consumidos. Por otro lado, el consumo de tabaco puede tambi\u00e9n favorecer la presencia de enfermedades que a su vez son factores de riesgo conocidos de NAC, como enfermedades periodontales e infecciones v\u00edricas de la v\u00eda a\u00e9rea superior. Como medida preventiva, si bien cabe proponer el abandono del tabaco, tambi\u00e9n es recomendable la vacuna neumoc\u00f3cica, independientement e de la presencia de comorbilidad. ATENCION PRIMARIA S24768654 A pesar de la accesibilidad a la EF deben realizarse esfuerzos para estandarizar la formaci\u00f3n, incrementar el n\u00famero de explo raciones y promover el control de calidad sistem\u00e1tico. S24768653 El grado de satisfacci\u00f3n de los pacientes de atenci\u00f3n primaria domiciliaria parece depender de las caracter\u00edsticas propias de cada modelo organizativo, siendo el modelo dispensarizado el que presenta un mayor grado de satisfacci\u00f3n o calidad asistencial per cibida. Se deber\u00eda realizar un mayor n\u00famero de estudios para generalizar estos resultados a otros centros de atenci\u00f3n primaria perten ecientes a otras instituciones. S24704194 El cigarrillo electr\u00f3nico (e -cig) es un dispositivo con forma de cigarrillo conven cional que libera determinadas dosis de vapores de nicotina a trav\u00e9s de un proceso de calentamiento electr\u00f3nico. Los cartuchos de nicotina tienen mucha variabilidad en la cantidad de nicotina liberada, incluso dentro de la misma marca. No todas las marcas admiten que contienen nicotina, pero esta se detecta en la mayor\u00eda de unidades analizadas. El e -cig contiene habitualmente propelentes como el propilenglicol, que es un producto irritante pulmonar. El efecto respiratorio a corto plazo del vapor de un e-cig es similar al causado por el humo del cigarrillo y es causa de broncoconstricci\u00f3n. La mayor\u00eda de marcas contienen glicerina, y s e ha detectado al menos un caso de neumon\u00eda lipoidea por esta sustancia. Muchas marcas contienen trazas de N -nitrosaminas, meta les pesados y otros productos que se encuentran en el humo de los cigarrillos convencionales en mucha mayor proporci\u00f3n. Actualmen te no se dispone de evidencia cient\u00edfica de que sea un dispositivo eficaz para dejar de fumar, por lo que no debe recomendarse de forma proactiva para este fin y puede interferir en el uso de tratamientos de evidencia cient\u00edfica demostrada para dejar de fumar. Puede tener un efecto indeseable al promover el inicio del consumo en adolescentes o retener a fumadores adultos en el con sumo de nicotina y en la dependencia gestual. No se conoce bien la toxicidad de los vapores pero se sabe que no son inocuos, por lo que no deber\u00edan utilizarse en espacios p\u00fablicos cerrados. S24661973 La prescripci\u00f3n inapropiada en mayores es frecuente y es t\u00e1 relacionada con el uso de benzodiacepinas de vida media larga. Existen diab\u00e9ticos con factores de riesgo cardiovascular en los que se omiten las estatinas. La polimedicaci\u00f3n juega un papel importa nte en las PPI y OP. S24703389 El EAT -26 modificado y abr eviado es un instrumento multidimensional, con excelentes valores de confiabilidad y sensibilidad, y con un adecuado valor de especificidad, apropiado para el cribado de posible TCA en poblaci\u00f3n de riesgo y \u00fatil en atenci\u00f3n primaria para su detecci\u00f3n tempr ana en mujeres j\u00f3venes. BRITISH MEDICAL JOURNAL S24865600 Screening for lung cancer with low dose computed tomography can reduce mortality from the disease by 20% in high risk smokers . This review covers the state of the art knowledge on several aspects of implementing a screening program. The most important are to identify people who are at high enough risk to warrant screening and the appropriate management of lung nodules found at scre ening. An accurate risk prediction model is more efficient than age and pack years of smoking alone at identifying those who wil l develop lung cancer and die from the disease. Algorithms are available for assessing people who screen the frequency and duration of screening and to refine risk prediction models so that they can be used to assess the risk of lung cancer in special populations. Ano ther important area is the use of computer vision software tools to facilitate high throughput interpretation of low of scan interpretation can be improved. Sufficient data ar e available to support the implementation of screening programs at the population level in stages that can be expanded when found to perform well to improve coronary reduce the need able degree. Our results but revascularisation treatment. REES Lower urinary tract symptoms (LUTS) in men have full avoids the assumption useful for men with LUTS a blockers are the usual treatment for LUTS due to BPH, and antimuscarinics for overactive bladder reductase inhibitors reduce the risk of clinical progression and sho uld be targeted at those at high risk of clinical progression A range of surgical options are available for fail initial medical management Lower urinary tract symptoms (LUTS) are common in men and increase in frequency and severity with age. Over one third of men aged 50 or more are living with moderate to severe symptoms, equating to 3.4 million men in the United Kingdom alone and 24 millio n in countries of the European Union.1 Most men with LUTS causes of LUTS in men and summarise the current evidence assessment and management of patients S24874977 Higher potency statin use is associated with a moderate increase in the r isk of new onset diabetes lower potency red ucing acute care use and hospital deaths at the end of life. S24879819 The effectiveness of thrombolytic therapy in daily clinical shown in randomised clinical trials and pooled analysis. was associated with favourable outcome in daily clinical practice, which underlines the speeding up the process for t therapy in hospital and before admission to achieve shorter time from door to needle the association betwe en 25(OH)D level and cause D supplementation were unavailable in journal articles and in trial registr y reports. There were inconsistencies between protocols and Clinical study reports be the for systematic reviews of drugs, but they should first be checked and the accuracy were simultaneous in suicide attempts among young people. It is essential to monitor and reduce possible unintended consequences of F DA warnings and media reporting. S2494238 8 This study found no evidence for a positive association between the use of drug treatments for ADHD and the risk of concomita nt suicidal behaviour among patients with ADHD. protective of stimulant the but improvements in clinical risk were small and did not reach statistical significance. Acceptabil ity was high for heart disease and repeat ed lifestyle intervention over five had effect on ischaemic he art disease, stroke, or particularly associated with increased health, criminal j ustice costs in adul thood. S24578445 Suicide risk the onset of the two types of illness. Closer collaboration between general and mental health services shoul d be an essential component of as a more complex intervention involving follow -up visits. CANADIAN MEDICAL ASSOCIATION JOURNAL S24664649 trial, the rate of successful radial -head rate in the not meet the non -inferiority margin, nurses were able to reduce radial head subluxation for almost 85% of children who presented and conditions. Health care providers, especially those assessing pat ients with mental health problems, n eed to be aware of the relation between specific types of child abuse and certain mental conditions. Success in preventing child abuse could lead reductions the prevalence chron ic diseases has also witnessed overall decline in hospital mortality; how increased. S24799511 A well -established body of scientific research there is a strong relationship between excess sodium intake and high Amer icans getting >75% of this evidence creates mounting pressure for less sodium in the food supply. The reduction of sodium in the food supply is comple x issue that involves multiple stakeholders. succes new approaches reducing will on product availability, mo difications, consumer acceptance, and cost. The conference facilitated an exchange of ideas and set the stage for to promote cardiovascular and prevent cardiovascular disease and will remain a priority for the American Heart Associatio n. DIABETES S24855154 Given the continued interest in defining the optimal management of individuals with type 2 diabetes, the Editor of Diabetes Ca re convened a working party of diabetes specialists to examine this topic in the context of insulin therapy. This was prompted b y recent new evidence on the use of insulin in such people. The group was aware of evidence that the benefits of insulin therapy are s till usually offered late, and thus the aim of the discussion was how to define the optimal timing and basis decisions re garding insulin these concepts in practice. It was noted that recent evidence had built upon that of the previous decades, together con firming benefits and albeit about ability hyperglycemia, the time of diagnosis in some circumstances, when metabolic control is disturbed by medical illness, procedures, or therapy, as well as in the longer in ambulatory care. For those previously starting insulin, various appropriate to individual needs . we review current evidence and circumstances in which insulin can be used, personalized targets for glycemic control in type 2 diabetes. S24595629 In the ACCORD BP trial, compared with combined standard treatment, in tensive or intensive glycemia treatment alone improved major CVD outcomes, without additional benefit from combining lipid trial, neither intensive t increased S24705610 The lesion strongest predictor, while recommended use of be limited, our results give some indication that a high level of SMB is associated with prol onged life expectancy in patients with type 2 diabetes highlight the potential impact of the patients' active contribution long trajectory of the disease. We assume that the used proxy for SMB is associated with unmeasured, but important, d imensions of health behavior. S24705609 GDM and pre -GDM in pregnancy has doubled over the last 14 years, and the overall burden of diabetes in pregnancy on society is growing. Although congenital anomaly rates mortality rates remain and with nondiabetic -management interventions to 2 diabetes appear to have a small beneficial effect on blood glucose control, and this effect was larger in the mobile phone subgroup. There was no evidence of benefit for other al, cognitive, behavioral, or emotional o utcomes. S24722494 Empagliflozin 10 and 25 mg for -on to metformin therapy significantly Specifically, analogs detemir) have less variability, on Ho wever, an argument against use of analog insulins as compared with use of regular or NPH insulin is o ne that states that the effectiveness and risk of hypoglycemia are the only two valid clinical outcomes that should used to compare the analog and human insulins. Thus, there remains a debate in some circles that analog insulins are no more effective th an human insulins, yet at a much higher financial cost. To provide an in -depth understanding of both sides of the argument, we provide a discussion of this topic as part of this two -part point - provide no clinical benefit compared with human insulins but cost much more. In the point narrati ve presented here, Dr. Grunberger provides a and clinical and suggests that when evaluating the \"cost\" of therapy, a much more global assessment is needed. -William T. CefaluEditor in Chief, Specifically, an argument against use of analog insulins as compared with use of regular or NPH insulin is one that states that the effectiven ess and ris k of hypoglycemia are the only two valid clinical outcomes that should used to compare the analog and human insulins. Thus, there remains a debate in some circles that analog insulins are no more effective than human insulins, yet at a much To provide an in sides of the argument, we provide a discussion of this topic as part of this two -part point - counterpoint narrative. In the counterpoint argument that provide no clinical benefit compared with human insulins but cost much more. In the preceding point narrative, Dr. Grunberger provides a defense of analog and their value in cl inical management and suggests that when evaluating the \"cost\" of therapy, a much more global assessment is needed. T. -quality studies have confirmed the central role of lithium in the treatment of bipolar disorder and have established lithium as the drug of first prophylaxis in this However, several indications for in un ipolar major depression are also based on sound evidence. This includes lithium augmentation as a main strategy for depressed patients an antidepressant, lithium for recurrent unipolar depression as an alternative to prophylax with antidepressant, and lithium's unique anti -suicidal properties. Lithium monotherapy, on the other hand, is not established for acute treatment of depression. Lithium therapy should be a core competency of every psychiatrist, enabling the safe use of lithium, to the benefit of our patients. S24866023 The epoch -making discovery of insulin heralded a new dawn in the management of diabetes. However, the earliest, unmodified soluble insulin preparations were limited by action, multiple daily injections. Initial the of the chemical and three and its analog to be introduced into clinical practice more than 10 years ago and is specifically designed to insulin suitable for -daily administration and reducing the risk of with -acting leading ng decisions. Some patients are slo w to respond to treatment, and TDM can shorten the time to response and to treatment completion. Normal plasma concentration ranges for the TB drugs have been defined. For practical reasons, only one or two samples are col lected post-dose. harvested and frozen. Isoniazid and ethionamide, in particular, are not stable in human serum at room temperature. Rifampicin is stable for more than 6 h under these conditions. Since our 2002 review, several papers regarding T B drug pharmacokinet ics, pharmacodynamics, and TDM have been published. Thus, we have better information regarding the concentrations required for effective TB therapy. to these drugs, short concept behind minimum order to but not all clinical data are consis tent with the utility of this The with diabetes and those infected with HIV have a particular risk for poor drug absorption, and for drug - is multi -drug interactions, and a decisive tool, allowing clinicians to successfully with stable heart disease, has been the source of much controversy in recent years; some have gone so far as to treat the med ication as a This the recent key stud ies, including meta -analyses, on the use trimetazidine in chronic heart failure, also in p atients with diabetes mellitus and arrhythmia, as well as in peripheral artery disease. This of Cardiology guidelines, including thos e of the use of trimetazidine in cardiovascular disease. S24866024 Approximately 30 % of HIV -infected patients are co -infected with hepatitis C virus (HCV). the release of highly active antiretroviral therapy, liver has become of morbidity and mortality in HIV patients. Prior to 201 1, HCV treatment pegylated ribavirin in HCV/HIV Recently, simeprevir and sofosbuvir have been approved by the US and Drug Administration (FDA) for HCV mono -infection. that safety profiles, and may complicate therapy. This for telaprevir are also relevant for locations not available. The especially if recurrent, were moderately associated with the risk of incident AMI. We had some indications that these associations arrhythmia and has gained increasingly more attention due to new treatment options, particularly catheter ablation. Growing experience with compared with antiarrhythmic medication have paved the way for its extended use and indication. At this point, it is recommended for symptomatic as first line therapy. It is a tempting concept to imp rove prognosis in young AF patients by rhythm control irrespective of symptoms. In this review, we summarize epidemiological data on young AF, efficacy, and limitations of rate and rhythm control by outcome, and the consequences of these data treatment in young, asymptomatic patients. S24282187 Cardiovascular disease (CVD) and depression are common. with CVD have more depression than the general populati on. Persons with depression are more likely to eventually CVD and than those patients not depressed. There is a g raded relationship: the more severe the depression, the higher the subsequent risk of mortality and other cardiovascular events. It is possible that depression is only a marker for more severe CVD which so causal relationship with either CVD causing mor e or more CVD and a worse prognosis for CVD is probable. There are many possible p athogenetic mechanisms that have been described, which and that might well be important. However, whether or not there is a causal relationship, depression is the main driver of quality of life and requires prevention, detection, and manageme nt in its own right. acute disease preventing progression. Large clinical trials performed to date have fa iled to show benefit of rhythm control compared with rate control, but these trials primarily included patients tages process. One possible explanation is that may improve Evolving observati ons progressive along with the occurrences of major complications such as str okes upon AF presentation, led to the notion that earlier and more active approaches to AF detection, rhythm -reversion, and maintenance of sinus rhythm may be a useful strategy in AF management. Approaches to early and sustained rhythm control include meas ures review, of res into the basis and management of AF in acute and early settings, is proposed cardiovascular ents shortly after outbursts of anger. FAMILY findings show that primary care hypertension patients who use a lipophilic beta -blocker are more likely to have higher depression scores than those who do not S24911299 Successful implementation preparing a workforce ready to practice in a new model of health care delivery. This qualitative study demonstrates that an experiential PCMH curriculum can enhance third -year student assessed knowledge of and attitudes toward the PCMH and currently of fer PBLI curricula. Additionally, less than one in family clerkships plan on increasing the amount of PBLI curricula in the next 12 months. Continued research in this area is needed to comprehensive CSC was well Based on a literature search and expert opinion, we have developed an information leaflet for GPs to provide as a supplement to oral to shoes with respect to patients' health insurance status indicate a need to address both communication skills in problems relatively small. GPs should at least chronic =5 medications, be ing female, of alone screenings were similar. Data derived from the SAF E study suggest that active screening for AF in patients aged =65 years in primary care ethical barriers to placebo use as perceived by a large sample of UK G Ps. Stand - alone qualitat ive work would provide and GPs their understanding of placebos and their clinical effects. S24532609 Our study shows a high burden o f care for fall -related injuries in older general practice patients and provides baseline its future monitoring. S24367069 The use of implementation strategies for the distribution guidelines on S24473676 within generalist whole to GPs to confidently screen patient encourage greater patient au JOURNAL OF THE AMERICAN MEDICAL S24915260 patients with diabetes who were receiving metformin, the addition of insulin vs a sulfonylurea was associated with an i ncreased risk of a composite of nonfatal cardiovascular for failure between 30% and 35% and less than 30%, survival at 3 years in who received a prophylactic ICD than in with o ther antibiotics was associated with a lower risk of 90 -day mortality and a smaller increased risk of myocardial infarction. These findings are consistent a net with the risk of ESRD and mortality, supporting consideration of lesser declines in estimated GFR (su ch as a 30% reduction over 2 years) as an alternative end point for CKD progression. S24866862 A structured, health reduced major mobility disability over 2.6 years among a dults at risk for disability. These findings suggest mobility benefit Exercise is with a greater redu ction in depression symptoms compared with no treatment, placebo, or active control interventions, such as relaxation or meditation. However, analysis in COPD Pulsed and pulsed antibiotics were associated with pressure benefits antagonists, such as whose bl ood pressure remains elevated after treatment with a 3 -drug regimen to maximal or near maximal doses. Resistant can significantly improve blood beyond medical therapy alone. The role of device therapy for better usual care better healing compared with usual care. PISANO Another spirited debate the the 25 - year follow -up results of the Canadian National Breast Screening no even though the CNBSS is the only one of 8 random ized clinic al trials of screening mammography that that created ned cohort with more cancers than the control group. Fourteen more recent studies published between 2001 and 2010 us ing more modern technology have shown a 25% to 50% reduction in breast cancer\u00e2\u20acrelated mortality for women aged 40 years.5 In the interval since the randomized trials of screening and with the supplanted film mammography as the screening technology of choice,7 and of reast cancer Addition increase the -term anxiety but not long -term anxiety, increase their sta ted willingness to travel to avoid a false -positive result. Our of -limited after screening mammograms is relevant for clinicians who counsel women on mammographic screening and for screening guideline development groups. S24710960 Sildenafil use may be associated with an increased risk of developing melanoma. Although this study is insufficient to alter clinical recommendations, we support a need for continued investigation of this association. S24733277 A health -related 24 psychotherapies are effective, but there is a lot of room for improvement. Because of the multiple differences are problematic. should also focus on how both be best combined to maximize synergy rather than debate the use of one treatment over the other. MEDICINA CLINICA S24387955 La comorbilidad FM empeora los par\u00e1metros cl\u00ednicos, la fatiga y la percepci\u00f3n de la calidad de vida en los pacientes con SFC. S23622897 Aproximadamente la mitad de los pacientes con DM2 no insulinizados y en tratamiento con HO presenta ICP. Cuatro de cada 10 pacientes cumplen adecuadamente el tratamiento con HO. El sexo femenino y una menor duraci\u00f3n de la DM2 se asocian independientemente a ICP. S24183117 El exceso de peso es un grave problema de salud p\u00fablica, con una importante mortalidad asociada. El an\u00e1lisis de los fallecimi entos atribuibles es una \u00fatil herramienta para conocer la situaci\u00f3n real y la monitorizaci\u00f3n de las medidas encaminadas a su control. S23683969 La DM2 se asocia a sobrepeso y obesidad y aumenta con el grado de IMC. Dislipidemia, hipertensi\u00f3n y sedentarismo en DM2 se incrementan con el aumento del IMC. Los pacientes con peor control metab\u00f3lico se asocian a mayor grado de obesidad. S24480288 La encefalopat\u00eda hep\u00e1tica (EH) es una complicaci\u00f3n frecuente de la cirrosis, con un gran impacto social, que deteriora la cal idad de vida del paciente y se considera un signo de enfermedad hep\u00e1tica avanzada y, por tant o, una indicaci\u00f3n cl\u00ednica para la evaluaci\u00f3n de trasplante hep\u00e1tico. Los pacientes que han presentado episodios de EH tienen un elevado riesgo de recurrencia, por lo que una vez superado el epis odio de EH se recomienda el control y la prevenci\u00f3n de factore s precipitantes (hemorragia digestiva, peritonitis bacteriana espont\u00e1nea, uso de los diur\u00e9ticos con precauci\u00f3n, evitar medicaci\u00f3n depresora del sistema nervioso), la administraci\u00f3n continuada de disac\u00e1ri dos no absorbibles, como lactitol o lactulosa, o de a ntibi\u00f3ticos poco o no absorbibles como rifaximina, y la valoraci\u00f3n de la necesidad de un trasplante hep\u00e1tico, dado que la presencia de un episodio de EH conlleva un mal pron\u00f3stico en la cirrosis. S24216018 El d\u00e9ficit de vitamina D y el s\u00edndrome metab\u00f3lico son 2 entidades muy frecuentes en poblaci\u00f3n espa\u00f1ola. Se ha sugerido que los pacientes con s\u00edndrome metab\u00f3lico pueden tener d\u00e9ficit de vitamina D con mayor frecuencia que los sujetos sin \u00e9l, y que unos valores bajos de vitamina D pueden predisponer al desa rrollo de s\u00edndrome metab\u00f3lico. No obstante, los resultados de estudios prospectivos y de intervenci\u00f3n han sido diversos, sin que se haya aclarado por el momento si existe esta relaci\u00f3n. El objetivo de este traba jo fue evaluar la relaci\u00f3n entre los valores de 25 -hidroxivitamina D y la prevalencia e incidencia del s\u00edndrome metab\u00f3lico. REVISTA ESPA\u00d1OLA DE CARDIOLOGIA S24863590 La aparici\u00f3n de los nuevos anticoagulantes orales como tratamiento de prevenci\u00f3n de fen\u00f3menos de tromboembolia en la fibrilac i\u00f3n auricular no valvular ha supuesto sin duda un significativo avance. Se ha estudiado la eficacia y la seguridad de los tres nuevos f\u00e1rmacos en ECA de no inferioridad (hip\u00f3tesis principal), en los que tambi\u00e9n se analizaban hip\u00f3tesis de superioridad. Aunque existe un l\u00f3gico entusiasmo por conocer qu\u00e9 f\u00e1rmaco es m\u00e1s eficaz, efectivo y eficiente, sin las pertinentes comparaciones directas no se podr\u00e1 obtener de manera fiable esa informaci\u00f3n. En todo caso, resulta razonable pensar que, conforme vaya pasando el tiempo y se tenga m\u00e1s datos de estudios observacionales, se ir\u00e1n definiendo las caracter\u00edsticas de la enfermedad \u2014pero, sobre todo, del paciente (comorbilidades, riesgo hemorr\u00e1gico, factores psicosociales, etc.) \u2014 y del entorno que definir\u00e1n las indicaciones prec isas de cada f\u00e1rmaco para grupos de pacientes concretos. S24863597 Actualmente est\u00e1 bien establecido que la alta reactividad plaquetaria a la adenosina difosfato durante el tratamiento con clo pidogrel es un factor independiente predictivo del riesgo de eve ntos isqu\u00e9micos en pacientes a los que se ha practicado una intervenci\u00f3n coronaria percut\u00e1nea. Sin embargo, el papel exacto de las pruebas de la funci\u00f3n plaquetaria sigue siendo objeto de controversia. Las pr uebas de la funci\u00f3n plaquetaria para asegurar un a inhibici\u00f3n plaquetaria \u00f3ptima han sido recomendadas por algunos autores para mejorar los resultados en los pacientes tratados con clopidogrel. En ensayos prospectivos y aleatorizados recientes sobre tratamiento antiagregante plaquetario personalizado, no se ha podido demostrar un efecto favorable de las pruebas de la funci\u00f3n plaquetaria en cuanto a mejora de los resultados cl\u00ednicos. En este art\u00edculo se analizan los mecanismos de la falta de respuesta a clopidogre l, los ensayos recientes de las pruebas de la funci\u00f3n plaquetaria y otros nuevos avances en el campo del tratamiento antiagregante plaquetario personalizado. S24863592 Este estudio aporta informaci\u00f3n desde una perspectiva nacional y muestra una prevalencia de factores de riesgo cardiovascular super ior en el sur de Espa\u00f1a, con estrecha correlaci\u00f3n con la obesidad, el estilo de vida sedentario e indicadores de una situaci\u00f3 n socioecon\u00f3mica desfavorecida. SCANDINAVIAN JOURNAL OF PRIMARY to better errors less than their young colleagues. Yo ung and more experienced GPs use different coping strategies for dealing with medical errors. Implications. When GPs become more experienced, they seem to get better at coping with medical errors. Means to support these skills should studied esearch. high utilizers of care, although is lower than that pr eviously reported. GAD - 7 is and detecting GAD among OGTTh may be a useful screening method risk groups such as hypertensive patients. S24931511 Overall, patients with a high CV risk were less likely to be prescribed an NSAID for musculoskeletal complaints than patients with a low CV risk. Nevertheless, one in five high CV risk patients received an NSAID, indicating that there is still room for improveme nt. THE LANCET S24613026 The excess risk of stroke associated with diabetes is significantly higher in women than men, independent of sex differences in other major cardiovascular risk factors. These data add to the existing evidence that men and women experience diabet es-related diseases differently and suggest all cardi associations are concordant, are not supported by findings high study. treatments, substantial. These f emphasise the need for new blood pressure -lowering strategies, and will help to inform associated with increased methylation at the HIF3A locus in blood cells and that perturbation factor rol in the response to increased weight in people. S24881995 If the same al l aspects of hypertension 80% of treated will have controlled blood pressure levels with a potential annual saving of about 50,000 major cardiovascular e vents. S24881993 Nebivolol and studies to importance of individual nutrients, foods, and dietary patterns in the prevention and management of type 2 diabetes. The quality of dietary fats and carbohydrates consumed is more crucial than is the quantity of Diets have been reduce the risk of diabetes and improve glycaemic control and blood lipids in patients with carbohydrate, and vegetarian diets can be tailored to personal and cultural food preferences and appropriate calorie needs for weight control and diabetes prevention and management. Although much progress has been made in development and ted to alleviate regional disparities. THE NEW ENGLAND JOURNAL OF MEDICINE S24795142 vesicoureteral reflux after a substantially risk of recurrence but not of renal scarring. (Funded by the National Institute of Diabetes and use during the first by the Agency for Healthcare Research and Quality and the National Institutes of Health.). S24918371 In adults with obesity and with either intervention alone. (Funded by NCT0371293 .). S24918372 multiple cardiovascular risk factors, the treatment o f obstructive sleep apnea with CPAP, but not nocturnal supplemental oxygen, resulted in a significant reduction in blood pressure. (Funded by the National Heart, Lung , and by oral linezolid for and skin infection. Treatment -daily vancomycin administered for 7 to 10 days for the treatment of acute bacterial skin and skin -structure infections "}